158 related articles for article (PubMed ID: 18176896)
1. GSK-3beta and oxidative stress in aged brain. Role of poly(ADP- -ribose) polymerase-1.
Songin M; Jeśko H; Czapski G; Adamczyk A; Strosznajder RP
Folia Neuropathol; 2007; 45(4):220-9. PubMed ID: 18176896
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
3. Effect of aging and oxidative/genotoxic stress on poly(ADP-ribose) polymerase-1 activity in rat brain.
Strosznajder RP; Jesko H; Adamczyk A
Acta Biochim Pol; 2005; 52(4):909-14. PubMed ID: 16302026
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
7. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH
Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483
[TBL] [Abstract][Full Text] [Related]
8. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.
Collino M; Aragno M; Castiglia S; Tomasinelli C; Thiemermann C; Boccuzzi G; Fantozzi R
Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784
[TBL] [Abstract][Full Text] [Related]
9. Age-related alteration of poly(ADP-ribose) polymerase activity in different parts of the brain.
Strosznajder JB; Jeśko H; Strosznajder RP
Acta Biochim Pol; 2000; 47(2):331-7. PubMed ID: 11051197
[TBL] [Abstract][Full Text] [Related]
10. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
11. [Suppressing poly(ADP-ribose)polymerase-1 inhibits tau phosphorylation in HEK293/tau441 cells].
Chen QH; Liao XM; Wang SH
Sheng Li Xue Bao; 2011 Dec; 63(6):511-6. PubMed ID: 22193445
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein inhibits poly (ADP-ribose) polymerase-1 (PARP-1) activity via NO-dependent pathway.
Adamczyk A; Kaźmierczak A
Folia Neuropathol; 2009; 47(3):247-51. PubMed ID: 19813144
[TBL] [Abstract][Full Text] [Related]
13. The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells.
Yin JQ; Wen L; Wu LC; Gao ZH; Huang G; Wang J; Zou CY; Tan PX; Yong BC; Jia Q; Shen JN
Toxicol Lett; 2013 Apr; 218(2):129-36. PubMed ID: 23164673
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain.
Bi X; Liu J; Yao Y; Baudry M; Lynch G
Am J Pathol; 2005 Oct; 167(4):1081-92. PubMed ID: 16192643
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
[TBL] [Abstract][Full Text] [Related]
16. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.
Rojo AI; Sagarra MR; Cuadrado A
J Neurochem; 2008 Apr; 105(1):192-202. PubMed ID: 18005231
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling.
Wang SJ; Wang SH; Song ZF; Liu XW; Wang R; Chi ZF
Neuroreport; 2007 Aug; 18(12):1285-9. PubMed ID: 17632284
[TBL] [Abstract][Full Text] [Related]
18. Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex.
Czapski GA; Cakala M; Kopczuk D; Strosznajder JB
Neurosci Lett; 2004 Feb; 356(1):45-8. PubMed ID: 14746898
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
20. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
